Press & News

Press & News

The latest information, recent news,
exciting events:
We will keep you up-to-date.

Press contact

Join the press mailing list


    I have read and accept your data policy.

    *Required fields


    How can we help you?

    You have come to the right place with your press enquiries and requests for information.

    Beate Dünschede
    +352 271802-29
    beate.duenschede@gsk-lux.com

    Send us a message

    Latest news & events

    Filter
    selected Reset selection
    Apply
    GSK Updates
    • 17 August 2022

      GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

      Read more
    • 10 February 2022

      GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

      Read more
    • 27 January 2022

      GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

      Read more
    • Law firm
      22 September 2022

      GSK Stockmann is shortlisted for the Legalcommunity Real Estate Awards 2022

      Following the announcement of the shortlists for the Legalcommunity Real Estate Awards 2022, GSK Stockmann has been nominated in three categories, namely Development & Construc...

      Read more
    • Career
      11 January 2021

      GSK Stockmann in Luxembourg certified as Great Place to Work®

      GSK Stockmann in Luxembourg has been certified as Great Place to Work® for 2020-2021 based on an anonymous online survey with more than 60 questions conducted by the Great Place t...

      Read more
    • Media review
      14 September 2022

      GSK Stockmann contributed to the publication of the Chambers Global Practice Guide – Private Equity

      The new edition of the Global Practice Guide – Private Equity has been published by Chambers. The guide features 42 jurisdictions and provides the latest legal information on mer...

      Read more

    It was some time ago, but
    is still worth knowing.

    In our news archive, you will find more reports that might interest you.

    News archive

    © GSK Stockmann 2022